991P - Retrospective study of weekly paclitaxel-cetuximab (WPC) in unselected patients (p) with recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN)

Autor: Bernad, I. Pajares, Trufero, J. Mártinez, Urquizu, L. Calera, de Miguel, A. Cebolleo, Cid, R. Pazo, Valero, M. Lanzuela, Agsustín, M.J., Millastre, E., Lobera, C. Santander, Alejandro, M. Alvarez, Gimeno, N., Yague, M. Malo, Llorente, Y., Torres, A. Antón

Publikováno v: In Annals of Oncology 1 October 2016 27 Supplement 6:vi342-vi342

Activity of weekly paclitaxel-cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors.

Autor: Bernad IP; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain. ispaber@hotmail.com., Trufero JM; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain., Urquizu LC; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain., Pazo Cid RA; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain., de Miguel AC; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain., Agustin MJ; Pharmacy Department, Miguel Servet University Hospital, Saragossa, Spain., Lanzuela M; Radiotherapy Department, Miguel Servet University Hospital, Saragossa, Spain., Antón A; Medical Oncology Department, Miguel Servet University Hospital, 1-3 Isabel la Catolica Avenue, 50009, Saragossa, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2017 Jun; Vol. 19 (6), pp. 769-776. Date of Electronic Publication: 2017 Jan 24.